USPTO Examiner ROBINSON KEITH O NEAL - Art Unit 1661

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19054476Grape Plant Named 'Resilience'February 2025April 2025Allow200NoNo
19042162Floribunda Rose Plant Named 'KORneukap'January 2025April 2025Allow300NoNo
18978805Bedding Rose Plant Named 'MEIWENTAR'December 2024March 2025Allow300NoNo
18976831Agapanthus Plant Named 'FO21BM110'December 2024March 2025Allow300NoNo
18972659STRAWBERRY PLANT NAMED 'DRISSTRAWONEHUNDREDTEN'December 2024March 2025Allow300NoNo
18957669Lagerstroemia Plant Named 'GV16103'November 2024February 2025Allow300NoNo
18956442LOBELIA PLANT NAMED 'WNLOBLRA26'November 2024February 2025Allow300NoNo
18956337CALIBRACHOA PLANT NAMED 'WNCALSBDBLGF26'November 2024February 2025Allow300NoNo
18957357HYBRID TEA ROSE PLANT NAMED 'WEKSELYAN'November 2024February 2025Allow300NoNo
18955808HELLEBORUS PLANT NAMED 'BORUSMURA25'November 2024February 2025Allow300NoNo
18947510BUDDLEIA PLANT NAMED 'SMNBAB'November 2024February 2025Allow300NoNo
18947467BIGNONIA PLANT NAMED 'SMNBFW'November 2024February 2025Allow300NoNo
18947758SYRINGA PLANT NAMED 'SMNSPWF'November 2024January 2025Allow200NoNo
18946906PHALAENOPSIS PLANT NAMED 'MI02815'November 2024January 2025Allow300NoNo
18935710Stachys plant named 'Key Lime'November 2024March 2025Allow410NoNo
18933419Hibiscus plant named 'G21087'October 2024February 2025Allow400NoNo
18925717Dianthus plant named 'G22090'October 2024March 2025Allow510NoNo
18924894STRAWBERRY PLANT NAMED 'DRISSTRAWONEHUNDREDEIGHT'October 2024January 2025Allow300NoNo
18831303BAPTISIA PLANT NAMED 'VANILLA CREAM II'October 2024March 2025Allow510NoNo
18831280Zamioculcas plant named 'EDZAM2202'October 2024March 2025Allow510NoNo
18912731Buddleja Plant Named 'Botex 013'October 2024January 2025Allow300NoNo
18911976PHLOX PLANT NAMED 'BALSASHINK'October 2024December 2024Allow200NoNo
18831234SEEDLESS GRAPEVINE PLANT NAMED 'ARD48'October 2024March 2025Allow610NoNo
18900593Erysimum Plant Named 'Cdcery3'September 2024December 2024Allow300NoNo
18831214LEUCANTHEMUM PLANT NAMED 'LEUZ0008'September 2024May 2025Allow810NoNo
18831202Epipremnum Plant Named 'KASCIGRFL'September 2024December 2024Allow300YesNo
18831179Rose plant named 'Poulpah126'September 2024February 2025Allow510NoNo
18831181Rose plant named 'Poulpar136'September 2024February 2025Allow510NoNo
18831184Rose plant named 'Poulvic001'September 2024February 2025Allow510NoNo
18817112ANTHURIUM PLANT NAMED 'AN2729837'August 2024November 2024Allow300NoNo
18831169Grapevine named 'SV35-179-125'August 2024April 2025Allow710NoNo
18810403PHLOX PLANT NAMED 'DOPHLOLAPIN'August 2024December 2024Allow300NoNo
18808032MANDEVILLA PLANT NAMED 'TVMD1252'August 2024November 2024Allow300NoNo
18808023MANDEVILLA PLANT NAMED 'TVMD908'August 2024November 2024Allow300NoNo
18807649Fragaria Plant Named 'DP64'August 2024November 2024Allow300NoNo
18800032Hydrangea Plant Named 'Bailpanthree'August 2024November 2024Allow300NoNo
18799941Cercis Plant Named 'JN100'August 2024February 2025Allow610NoNo
18799767Primula plant named 'Kerannaweave'August 2024January 2025Allow510NoNo
18799979Camellia Plant Named 'Gordon's Flash'August 2024November 2024Allow300NoNo
18798378Apple Tree Named 'PremA133'August 2024February 2025Allow610NoNo
18797429Maclura Plant Named 'Hibbard'August 2024November 2024Allow300NoNo
18785548HOP PLANT NAMED 'IH151343'July 2024February 2025Allow710NoNo
18831118Spigelia plant named 'Orange Slices'July 2024February 2025Allow710NoNo
18771592Mandarin Tree Named 'AC4916'July 2024February 2025Allow710NoNo
18769925PHALAENOPSIS PLANT NAMED 'PHA899665'July 2024October 2024Allow300NoNo
18766385CALIBRACHOA PLANT NAMED 'KLECA23958'July 2024February 2025Allow710NoNo
18831086Cornus plant named 'NCCH3'June 2024February 2025Allow810NoNo
18755613SALVIA PLANT NAMED 'DPWSAFUWHT'June 2024September 2024Allow300NoNo
18751578MANDARIN PLANT NAMED 'RES 19-56'June 2024April 2025Allow1020NoNo
18751529LEMON PLANT NAMED 'CE-D5-1-9-42'June 2024March 2025Allow910NoNo
18752254STRAWBERRY PLANT NAMED 'DRISSTRAWONEHUNDREDSIX'June 2024September 2024Allow300NoNo
18745850Viburnum plant named 'NCVX5'June 2024December 2024Allow610NoNo
18740051STRAWBERRY PLANT NAMED 'DRISSTRAWONEHUNDREDFIVE'June 2024September 2024Allow300NoNo
18735110PHALAENOPSIS PLANT NAMED 'GLITZY'June 2024October 2024Allow400NoNo
18735094PHALAENOPSIS PLANT NAMED 'BODY LANGUAGE'June 2024September 2024Allow400NoNo
18679391Agapanthus Plant Named 'HPP4087'May 2024September 2024Allow300NoNo
18677471Apple Tree Named 'PremA019'May 2024November 2024Allow610NoNo
18831053PELARGONIUM PLANT NAMED 'PEQZ0105'May 2024August 2024Allow300NoNo
18668283Aristeria plant named 'D Clash'May 2024November 2024Allow610NoNo
18667173Hybrid Tea Rose Plant Named 'KORclagran'May 2024August 2024Allow300NoNo
18665795Buddleja Plant Named 'Botex 007'May 2024August 2024Allow300NoNo
18664897NEW GUINEA IMPATIENS PLANT NAMED 'DONGIMAVIOSTA'May 2024December 2024Allow710NoNo
18664836NEW GUINEA IMPATIENS PLANT NAMED 'DONGIMAROSTAR'May 2024October 2024Allow500NoNo
18665111DAHLIA PLANT NAMED 'DODASUMBEREBIC'May 2024January 2025Allow810NoNo
18662982LANTANA PLANT NAMED 'DOLANTRALAPI'May 2024August 2024Allow300NoNo
18659971RASPBERRY PLANT NAMED 'STELLA'May 2024December 2024Allow710NoNo
18657770CALADIUM PLANT NAMED 'RSB Rd (BOM) 2319-279'May 2024August 2024Allow300NoNo
18657482DIANTHUS PLANT NAMED 'KLEDG23495'May 2024December 2024Allow710NoNo
18657774CALADIUM PLANT NAMED 'RUF OF18-231'May 2024August 2024Allow300NoNo
18657594Heliopsis Plant Named 'VAR006'May 2024August 2024Allow300NoNo
18656230Raspberry Plant Named 'Simona'May 2024January 2025Allow810NoNo
18638468BLACKBERRY PLANT NAMED �HFG B2008T�April 2024August 2024Allow410NoNo
18628441Petchoa Plant Named 'Balpetcel145'April 2024August 2024Allow400NoNo
18624363Avocado tree named 'Guacacado'April 2024October 2024Allow610NoNo
18624029MANDEVILLA PLANT NAMED 'SUNPA 13872'April 2024August 2024Allow400NoNo
18620763SENECIO PLANT NAMED 'SENE TOYONAI'March 2024August 2024Allow400NoNo
18445926Olive Tree Named 'I 46'March 2024January 2025Allow1010NoNo
18615373Hybrid Tea Rose Plant Named 'MEILEHAGAN'March 2024October 2024Allow700NoNo
18614654Delosperma Plant Named 'FSDD2112'March 2024July 2024Allow400NoNo
18613007ECHINACEA PLANT NAMED 'IFECSSMS'March 2024July 2024Allow400NoNo
18610226ANTHURIUM PLANT NAMED 'AN2824056'March 2024July 2024Allow400NoNo
18610248ANTHURIUM PLANT NAMED 'AN2824663'March 2024July 2024Allow400NoNo
18607510ANTHURIUM PLANT NAMED 'AN2494662'March 2024July 2024Allow400NoNo
18607503ANTHURIUM PLANT NAMED 'AN2437252'March 2024July 2024Allow400NoNo
18603176Erysimum Plant Named 'Cdcery1'March 2024July 2024Allow400NoNo
18445831Campanula plant named `Midnight'February 2024February 2025Abandon1210NoNo
18445832STRAWBERRY PLANT VARIETY NAMED 'PLARED 18145'February 2024October 2024Allow710NoNo
18585368Silene Plant Named 'Sil005'February 2024July 2024Allow400NoNo
18585437Vriesea Plant Named 'MULTRED'February 2024August 2024Allow510NoNo
18585907PELARGONIUM PLANT NAMED �KLEIP23785�February 2024September 2024Allow710NoNo
18583849POINSETTIA PLANT NAMED �NPCW23402�February 2024June 2024Allow400NoNo
18581381FUCHSIA PLANT NAMED 'DOFUCHBALREL'February 2024July 2024Allow500NoNo
18581252CUPHEA PLANT NAMED 'DOCUPLA 24'February 2024June 2024Allow400NoNo
18444739COLEUS PLANT NAMED 'DOCOLDOTONAS'February 2024July 2024Allow500NoNo
18441346Delosperma Plant Named 'S3whi'February 2024October 2024Allow810NoNo
18438423Hemerocallis Plant Named 'Huhe01'February 2024June 2024Allow400NoNo
18437021ARABIS PLANT NAMED �ARCTIC FOX�February 2024June 2024Allow400YesNo
18430001Campanula plant named 'Chameleon Blue'February 2024August 2024Allow710NoNo
18445781BEGONIA PLANT NAMED 'BEYZ0002'January 2024October 2024Allow810YesNo
18445776Phlox plant named �Material Girl'January 2024October 2024Allow910NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ROBINSON, KEITH O NEAL.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
2
Examiner Affirmed
2
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
0.9%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
25
Allowed After Appeal Filing
10
(40.0%)
Not Allowed After Appeal Filing
15
(60.0%)
Filing Benefit Percentile
62.7%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 40.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner ROBINSON, KEITH O NEAL - Prosecution Strategy Guide

Executive Summary

Examiner ROBINSON, KEITH O NEAL works in Art Unit 1661 and has examined 1,930 patent applications in our dataset. With an allowance rate of 96.1%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 15 months.

Allowance Patterns

Examiner ROBINSON, KEITH O NEAL's allowance rate of 96.1% places them in the 88% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by ROBINSON, KEITH O NEAL receive 0.71 office actions before reaching final disposition. This places the examiner in the 6% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ROBINSON, KEITH O NEAL is 15 months. This places the examiner in the 99% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a -0.9% benefit to allowance rate for applications examined by ROBINSON, KEITH O NEAL. This interview benefit is in the 8% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 23.9% of applications are subsequently allowed. This success rate is in the 24% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 75.0% of cases where such amendments are filed. This entry rate is in the 93% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 120.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 80% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 90.5% of appeals filed. This is in the 81% percentile among all examiners. Of these withdrawals, 63.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 81.9% are granted (fully or in part). This grant rate is in the 93% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.4% of allowed cases (in the 57% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.